FSD Pharma Inc - Class B - Class B (Sub Voting) (QNTM) 4.05 USD (-0.05%)

FSD Pharma Inc is involved in the research and development of cannabis-based medications and other substances to treat chronic diseases.

medical-research

Comment

Performance & Momentum

6 Months –

1 Year –

3 Years –

5 Years 96.37 %

Momentum

Unlock this indicator

Strategic Analysis

FSD Pharma Inc is positioned in the innovative niche of medical treatments based on cannabis and related substances, with a model focused on research and development to address the needs of chronic diseases. Its specialized approach aims to capture a growing segment of the biotech healthcare market, despite a challenging competitive environment.

Strengths

Strong expertise in medical research related to therapeutic cannabis
Potential to develop innovative treatments for chronic diseases

Weaknesses

Significantly deteriorated financial performance over the long term
Lack of recent catalysts or favorable news to support the share price

Momentum

The stock's momentum is very weak, reflecting investor disinterest and a pronounced downward trend over several years. This environment calls for heightened caution and suggests that clear reversal signals will be needed before any positive re-rating.

Analysis performed 1 month ago